Lipidomic Profiling of PFOA-Exposed Mouse Liver by Multi-Modal Mass Spectrometry Analysis

Perfluorooctanoic acid (PFOA) is a synthetic perfluorinated chemical classified as a persistent organic pollutant. PFOA has been linked to many toxic effects, including liver injury. Many studies report that PFOA exposure alters serum and hepatic lipid metabolism. However, lipidomic pathways altered by PFOA exposure are largely unknown and only a few lipid classes, mostly triacylglycerol (TG), are usually considered in lipid analysis. Here, we performed a global lipidomic analysis on the liver of PFOA-exposed (high-dose and short-duration) and control mice by combining three mass spectrometry (MS) techniques: liquid chromatography with tandem mass spectrometry (LC–MS/MS), matrix-assisted laser desorption ionization mass spectrometry imaging (MALDI-MSI), and time-of-flight secondary ion mass spectrometry (TOF-SIMS). Among all hepatic lipids identified by LC–MS/MS analysis, more than 350 were statistically impacted (increased or decreased levels) after PFOA exposure, as confirmed by multi-variate data analysis. The levels of many lipid species from different lipid classes, most notably phosphatidylethanolamine (PE), phosphatidylcholine (PC), and TG, were significantly altered. Subsequent lipidomic analysis highlights the pathways significantly impacted by PFOA exposure, with the glycerophospholipid metabolism being the most impacted, and the changes in the lipidome network, which connects all the lipid species together. MALDI-MSI displays the heterogeneous distribution of the affected lipids and PFOA, revealing different areas of lipid expression linked to PFOA localization. TOF-SIMS localizes PFOA at the cellular level, supporting MALDI-MSI results. This multi-modal MS analysis unveils the lipidomic impact of PFOA in the mouse liver after high-dose and short-term exposure and opens new opportunities in toxicology.

[1]  J. Xia,et al.  Using MetaboAnalyst 5.0 for LC–HRMS spectra processing, multi-omics integration and covariate adjustment of global metabolomics data , 2022, Nature Protocols.

[2]  Tina B. Angerer,et al.  Evaluation of 6 MALDI-Matrices for 10 μm Lipid Imaging and On-Tissue MSn with AP-MALDI-Orbitrap , 2022, Journal of the American Society for Mass Spectrometry.

[3]  J. Pauling,et al.  Lipid network and moiety analysis for revealing enzymatic dysregulation and mechanistic alterations from lipidomics data , 2022, bioRxiv.

[4]  M. Orešič,et al.  Exposure to environmental contaminants is associated with altered hepatic lipid metabolism in non-alcoholic fatty liver disease. , 2021, Journal of hepatology.

[5]  R. Ahrends,et al.  Recommendations for good practice in MS-based lipidomics , 2021, Journal of lipid research.

[6]  J. Pauling,et al.  Investigating Global Lipidome Alterations with the Lipid Network Explorer , 2021, Metabolites.

[7]  Yangyang Zhang,et al.  Distribution of perfluorooctane sulfonate in mice and its effect on liver lipidomic. , 2021, Talanta.

[8]  B. Lindeman,et al.  Systemic PFOS and PFOA exposure and disturbed lipid homeostasis in humans: what do we know and what not? , 2021, Critical reviews in toxicology.

[9]  T. Fletcher,et al.  Associations between perfluoroalkyl substances and lipid profile in a highly exposed young adult population in the Veneto Region. , 2020, Environment international.

[10]  Heather M. Wallace,et al.  Risk to human health related to the presence of perfluoroalkyl substances in food , 2020, EFSA journal. European Food Safety Authority.

[11]  S. Rizzoli,et al.  Novel Secondary Ion Mass Spectrometry Methods for the Examination of Metabolic Effects at the Cellular and Subcellular Levels , 2020, Frontiers in Behavioral Neuroscience.

[12]  R. Caprioli,et al.  Combining Salt Doping and Matrix Sublimation for High Spatial Resolution MALDI Imaging Mass Spectrometry of Neutral Lipids. , 2019, Analytical chemistry.

[13]  M. Belov,et al.  Transmission-mode MALDI-2 mass spectrometry imaging of cells and tissues at subcellular resolution , 2019, Nature Methods.

[14]  Christer S. Ejsing,et al.  Automated, parallel mass spectrometry imaging and structural identification of lipids , 2018, Nature Methods.

[15]  Lixi Zeng,et al.  Global distribution of perfluorochemicals (PFCs) in potential human exposure source-A review. , 2017, Environment international.

[16]  Bin Yang,et al.  Effect of acute exposure to PFOA on mouse liver cells in vivo and in vitro , 2017, Environmental Science and Pollution Research.

[17]  J. Corton,et al.  Perfluoroalkyl acids-induced liver steatosis: Effects on genes controlling lipid homeostasis. , 2017, Toxicology.

[18]  L. Ma,et al.  Molecular mechanisms of PFOA-induced toxicity in animals and humans: Implications for health risks. , 2017, Environment international.

[19]  Xianlin Han,et al.  Lipidomics: Techniques, Applications, and Outcomes Related to Biomedical Sciences. , 2016, Trends in biochemical sciences.

[20]  Xianlin Han,et al.  Lipidomics for studying metabolism , 2016, Nature Reviews Endocrinology.

[21]  J. Depierre,et al.  Complement activation is involved in the hepatic injury caused by high-dose exposure of mice to perfluorooctanoic acid. , 2015, Chemosphere.

[22]  Michael J. Eller,et al.  Time‐of‐flight secondary ion mass spectrometry imaging of biological samples with delayed extraction for high mass and high spatial resolutions , 2015, Rapid communications in mass spectrometry : RCM.

[23]  Masanori Arita,et al.  MS-DIAL: Data Independent MS/MS Deconvolution for Comprehensive Metabolome Analysis , 2015, Nature Methods.

[24]  David S. Wishart,et al.  MetaboAnalyst 3.0—making metabolomics more meaningful , 2015, Nucleic Acids Res..

[25]  A. Walch,et al.  MALDI Imaging mass spectrometry: current frontiers and perspectives in pathology research and practice , 2015, Laboratory Investigation.

[26]  Jian’an Liu,et al.  Mass Spectrometry Methodology in Lipid Analysis , 2014, International journal of molecular sciences.

[27]  P. de Voogt,et al.  Perfluorinated alkylated acids in groundwater and drinking water: identification, origin and mobility. , 2013, The Science of the total environment.

[28]  G. Jiang,et al.  Specific Accumulation of Lipid Droplets in Hepatocyte Nuclei of PFOA-exposed BALB/c Mice , 2013, Scientific Reports.

[29]  G. Xie,et al.  High Fat Diet Feeding Exaggerates Perfluorooctanoic Acid-Induced Liver Injury in Mice via Modulating Multiple Metabolic Pathways , 2013, PloS one.

[30]  Julien Breault-Turcot,et al.  Silver-assisted laser desorption ionization for high spatial resolution imaging mass spectrometry of olefins from thin tissue sections. , 2013, Analytical chemistry.

[31]  Y. Kawano,et al.  Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease , 2013, Journal of Gastroenterology.

[32]  A. Glynn,et al.  Dietary exposure to perfluoroalkyl acids for the Swedish population in 1999, 2005 and 2010. , 2012, Environment international.

[33]  J. Butenhoff,et al.  Multiplicity of nuclear receptor activation by PFOA and PFOS in primary human and rodent hepatocytes. , 2011, Toxicology.

[34]  P. Hayes,et al.  Review article: omega‐3 fatty acids – a promising novel therapy for non‐alcoholic fatty liver disease , 2009, Alimentary pharmacology & therapeutics.

[35]  M. Rosen,et al.  Comparative Hepatic Effects of Perfluorooctanoic Acid and WY 14,643 in PPAR-α Knockout and Wild-type Mice , 2008, Toxicologic pathology.

[36]  J Christopher Corton,et al.  Toxicogenomic dissection of the perfluorooctanoic acid transcript profile in mouse liver: evidence for the involvement of nuclear receptors PPAR alpha and CAR. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[37]  A. A. Jensen,et al.  Emerging endocrine disrupters: perfluoroalkylated substances. , 2008, International journal of andrology.

[38]  Bernhard Liebl,et al.  Intake of phthalates and di(2-ethylhexyl)adipate: results of the Integrated Exposure Assessment Survey based on duplicate diet samples and biomonitoring data. , 2007, Environment international.

[39]  T. Ebbels,et al.  Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts , 2007, Nature Protocols.

[40]  C. Lau,et al.  Perfluoroalkyl acids: a review of monitoring and toxicological findings. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[41]  A. Calafat,et al.  Polyfluoroalkyl Chemicals in the U.S. Population: Data from the National Health and Nutrition Examination Survey (NHANES) 2003–2004 and Comparisons with NHANES 1999–2000 , 2007, Environmental health perspectives.

[42]  Damià Barceló,et al.  Environmental analysis of fluorinated alkyl substances by liquid chromatography–(tandem) mass spectrometry: a review , 2006, Analytical and bioanalytical chemistry.

[43]  D. Vance,et al.  The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis. , 2006, Cell metabolism.

[44]  A. J. Hulbert,et al.  Dietary fats and membrane function: implications for metabolism and disease , 2005, Biological reviews of the Cambridge Philosophical Society.

[45]  H. Shimano,et al.  Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP‐1 suppression , 2003, Hepatology.

[46]  N. Kudo,et al.  Fish oil-feeding prevents perfluorooctanoic acid-induced fatty liver in mice. , 1997, Toxicology and applied pharmacology.